Urodelia, a Toulouse (France) biotech company specialized in personalised anti-cancer therapeutic vaccine, and 4P-Pharma, a Lille (France) biotech company specialised in human and animal drug development, are pleased to announce that they established a business development partnership. As an exclusive partner, 4P-Pharma will seek strategic opportunities in Animal Health for the licensing-out of Urodelia’s Apa.vac® anticancer therapeutic vaccine.
Read the full press release
English version: PR_Urodelia_4P-Pharma_EN
French version: PR_Urodelia_4P-Pharma_FR
Press Contacts:
Urodelia press contact
Camille Bayol, Project Manager
Phone: +33 (0)5 34 47 86 10 – E-mail: Camille.bayol@urodelia.com
4P-Pharma press contact
Roselina Lam, Business developer
Phone: +33 (0)9 50 72 97 68 – E-mail: roselina@4p-pharma.com